Cervical squamous intraepithelial neoplasia
MONDO:0042491A neoplastic process that affects the squamous epithelium of the cervix. It is classified as cervical squamous intraepithelial neoplasia 1, 2, or 3, according to the degree of squamous cell maturation and cellular atypia, and the number of mitotic figures.
Also known as: CIN, cervical sil, cervical squamous intraepithelial lesion, cervical squamous intraepithelial neoplasia, cervix squamous intraepithelial lesion, cervix uteri sil, cervix uteri squamous intraepithelial lesion, squamous intraepithelial lesion of cervix
1472 clinical trials for this condition and its sub-types, 28 tagged with Cervical squamous intraepithelial neoplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a cream after surgery stop cervical cancer in HIV-Positive women?
Disease control CompletedThis study looked at whether using an anti-cancer cream (5-fluorouracil) in the vagina after surgery is an acceptable and feasible way to treat cervical precancer in 180 South African women living with HIV. The goal was to see if women would stick with the treatment and find it a…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Experimental DNA vaccine targets HPV to fight precancerous cervical cells
Disease control CompletedThis early-stage trial tested a DNA vaccine called NWRD08 in 9 women with high-grade cervical lesions caused by HPV types 16 or 18. The vaccine was given as a shot followed by a mild electrical pulse to help cells take it up. The main goal was to check safety and see if the vacci…
Phase 1 • Sponsor: Newish Technology (Beijing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
HPV vaccine shows promise in cutting cervical lesion risk for HIV-Positive women
Disease control CompletedThis study looked at whether the HPV vaccine can help prevent high-grade cervical lesions (precancerous growths) in women living with HIV who were already being treated for HPV. About 536 women took part, receiving either the HPV vaccine or a placebo. The goal was to see if the v…
Phase 3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC